NIH-funded research R21 grant

Tracking drug-resistant gonorrhea using advanced genetic testing.

Official title: Whole Genome Sequencing of N. gonorrhoeae from Non-Culture Based Clinical Specimens to Surveil for Emerging Resistance

Funded at Rush University Medical Center · NIH-10951805 · Data updated 2026-11-12

This study is looking at how drug-resistant gonorrhea spreads, especially in communities like men who have sex with men, to help improve health responses and understand the effects of COVID-19 on gonorrhea rates.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRush University Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startAugust 15, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$243,361
NIH project number1R21AI185529-01
Project IDNIH-10951805 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with gonorrhea, particularly those from communities with high rates of drug resistance.

Less likely to help

Patients who do not have gonorrhea or are not part of high-risk communities may not benefit from this research.

What this research studies

This research focuses on understanding the spread of drug-resistant Neisseria gonorrhoeae, a significant public health threat. By utilizing whole genome sequencing on clinical specimens that are not typically cultured, the study aims to identify emerging strains of gonorrhea and their resistance patterns. This approach will enhance surveillance efforts, particularly in communities heavily affected by the disease, such as men who have sex with men. The research also addresses the impact of the COVID-19 pandemic on gonorrhea rates and aims to improve public health responses.

Why it matters

Potential benefit: If successful, this research could lead to better detection and management of drug-resistant gonorrhea, ultimately improving patient outcomes.

How similar studies have gone: Previous research has successfully utilized whole genome sequencing for other bacterial infections, indicating potential for success in this novel application.

Where this research is happening

  • Rush University Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Popovich, Kyle Jeanne — Rush University Medical Center
  • Study coordinator: Popovich, Kyle Jeanne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.